Australian Gonococcal Surveillance Programme, 1 January to 31 March 2013
DOI:
https://doi.org/10.33321/cdi.2013.37.43Keywords:
antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeaeAbstract
The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on sensitivity to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). The AGSP data are presented quarterly in tabulated form, as well as in the AGSP annual report. This report presents national gonococcal antimicrobial resistance surveillance data for the indicated quarter.
Downloads
References
Management of Sexually Transmitted Diseases. World Health Organization 1997; Document WHO/GPA/TEM94.1 Rev.1 p 37.
Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia. Sex Health 2013;10(5):460–462.
Chen M, Stevens K, Tideman R, Zaia A, Fairley CK, Lahra MM, Hogg G. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother 2013;68(6):1445–1447.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2013 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
